A recent acquisition coupled with solid organic growth have given Procter & Gamble stock a lift Thursday.

The consumer packaged goods company raised its guidance for its all-in sales growth, thanks to its recent acquisition of health and supplement brand Thorne. On top of that acquisition, Proctor & Gamble saw growth increases across all its product categories, a big turnaround from the prior quarter when some segments were flat or slightly lower.

Revenue grew 4% to $23.28 billion in the fiscal first quarter, above Wall Street's call for $22.79 billion. Adjusted earnings of $2 a share topped analysts' consensus estimates of $1.88.

"While we expect there will continue to be geopolitical and economic challenges, this strong start keeps us on track to deliver within our guidance ranges for organic sales growth, core EPS growth and free cash flow productivity for the fiscal year," CEO Shailesh Jejurikar said Thursday.

Shares of Procter & Gamble advanced 3.2% to $161.88 in premarket trading Thursday.

Procter & Gamble raised its outlook for all-in sales growth, saying it now expects a 2% to 4% growth range, up from previous guidance of 1% to 3%. It also reiterated its fiscal 2027 guidance, anticipating adjusted earnings to range from $6.89 to $7.11 a share. Procter & Gamble said it still expects organic sales to grow 1% to 3%.

Wall Street forecasts fiscal 2027 earnings of $6.97 a share with sales growing about 2.1%, according to FactSet.

Management attributed the all-in sales guidance boost to its acquisition of health and supplement brand Thorne for $3.8 billion, which was completed as of Oct. 1. The company previously announced the deal in early August.

Each of Procter & Gamble's product categories, which range from baby care to hair care, saw a boost in the first quarter. For the period, from July to September, the beauty segment rose 5% from a year ago, with other businesses like health care and home products growing 3% and 5%, respectively.